TORASEMID Mepha cpr 200 mg 100 pce
7680587690042
CH-58769
C03CA04
05.01.0.
Active substances:
1 / 3
google
Details
- Product number
- 5876901
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- torasemidum 200 mg, magnesii stearas, cellulosum microcristallinum, cellulosi pulvis, carmellosum natricum conexum, natrium 0.04 mg, silica colloidalis anhydrica, pro compresso.
Articles (1)
Torasemid-Mepha 200, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
torasemidum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
magnesii stearas
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
cellulosi pulvis
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.04 MG | Substance | HBESI |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 63.40
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2009
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 58769
- Drug name
- Torasemid-Mepha 200, Tabletten
- Galenic form
- TAB
- ATC Code
- C03CA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/05/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 05.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TORASEMID Mepha cpr 200 mg 100 pce
- Description (DE)
- TORASEMID Mepha Tabl 200 mg 100 Stk
- Market launch
- 14/05/2009
- Narcotic (BTM)
- No